Analysts Recommendations Valeant Pharmaceuticals International, Inc. (VRX)

Now have a look at past performance (weekly performance to year to date performance) how Valeant Pharmaceuticals International, Inc. Scotiabank decreased their price objective on Valeant Pharmaceuticals International from $15.00 to $12.00 and set a "sector perform" rating for the company in a report on Wednesday, April 26th. Hedge funds and other institutional investors own 50.45% of the company's stock. Live Your Vision Limited Liability Com has 0.01% invested in Valeant Pharmaceuticals Intl Inc (NYSE:VRX).

05/15/2017 - Valeant Pharmaceuticals International, Inc. had its "hold" rating reiterated by analysts at Barclays. Oxford Asset Management purchased a new position in shares of Valeant Pharmaceuticals International during the fourth quarter worth $2,403,000.

The Stock traded with an actual day volume of 19.29 Million and average volume of 23.51 Million respectively. They now have a $10.00 price target on the specialty pharmaceutical company's stock. On December 15 the stock rating was downgraded from "Neutral" to "Equal-Weight" and a price target of $17.00 was set in a statement from Morgan Stanley. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Hsbc Holdg Public Ltd Com holds 0.01% in Valeant Pharmaceuticals Intl Inc (TSE:VRX) or 312,267 shares. World Asset Management Inc now owns 21,502 shares of the specialty pharmaceutical company's stock valued at $237,000 after buying an additional 328 shares during the last quarter. Alyeska Invest Grp Lp owns 1.51M shares for 0.2% of their portfolio. The company's market capitalization is $5.65 billion.

Valeant Pharmaceuticals International, Inc. has a 50 day moving average of 13.59 and a 200 day moving average of 12.98. For the past 5 years, the stock's EPS growth has been almost -17.00%.

Valeant Pharmaceuticals International (NYSE:VRX) (TSE:VRX) last posted its earnings results on Tuesday, May 9th.

05/09/2017 - Valeant Pharmaceuticals International, Inc. had its "neutral" rating reiterated by analysts at BTIG Research.

Several other equities research analysts also recently issued reports on VRX. Gruss & Co. Inc. acquired a new position in Valeant Pharmaceuticals International during the first quarter worth about $104,000. The specialty pharmaceutical company reported $2.80 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.87 by $1.93. The business had revenue of $2.11 billion for the quarter, compared to analyst estimates of $2.17 billion. Valeant Pharmaceuticals International had 35 analyst reports since October 20, 2015 according to SRatingsIntel.

WARNING: "Valeant Pharmaceuticals International, Inc".

In terms of Valeant Pharmaceuticals International, Inc. If you are accessing this report on another publication, it was stolen and reposted in violation of US & global copyright laws. The original version of this piece can be viewed at During the same quarter in the previous year, the firm posted ($1.08) earnings per share.

In other Valeant Pharmaceuticals International news, Director Schutter Richard U. De acquired 20,000 shares of the business's stock in a transaction on Thursday, May 11th. Gulf International Bank UK Ltd increased its position in shares of Valeant Pharmaceuticals International by 1.1% in the first quarter. The stock was purchased at an average cost of C$13.90 per share, for a total transaction of C$278,000.00. (VRX) have 351.90 million outstanding shares now held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Private Advisor Group LLC increased its position in shares of Valeant Pharmaceuticals International by 23.2% in the fourth quarter. The Lagoda Investment Management Lp holds 36,119 shares with $5.94M value, down from 53,579 last quarter. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has declined 48.51% since July 10, 2016 and is downtrending. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women.

Like this


10 July 2017
Malayalam actress molestation case: Actor Dileep arrested on conspiracy charges
While Suni and his accomplices were arrested within a week of the kidnapping, police stumbled upon the conspiracy angle last week. The actress was kidnapped on February 17, and later the news went viral with the photographs which were taken by the kidnappers.

10 July 2017
Church Of England Considering Special Services To Celebrate Gender Reassignment
Supporters said such a welcome would help people undergoing the trauma of transition or transphobic bullying. The vote took place during the Church of England's general synod meeting which began Friday.

10 July 2017
Governance deficit in many states says, NITI Aayog CEO Amitabh Kant
The PM emphasised the importance of preserving institutional memory, NITI Aayog Vice Chairman Arvind Panagariya said. He gave the example of monthly PRAGATI meetings, which had given a decisive push to many long-pending projects.

10 July 2017
INLD to block entry of Punjab vehicles
Security personnel in riot gear, riot-control vehicles and other equipment were deployed at all points to maintain law and order. The party claimed that their protest was peaceful, adding that services of emergency vehicles like ambulances were not stopped.

10 July 2017
What are Analyst's Indicators for California Resources Corporation (CRC), Vantiv, Inc. (VNTV)
If you are viewing this story on another site, it was stolen and republished in violation of global copyright and trademark law. First Quadrant L P CA acquired a new stake in shares of Antero Resources Corporation during the first quarter worth $141,000.

10 July 2017
Pledging reforms by 2020, Ukraine seeks roadmap to NATO membership
His Russian counterpart, Foreign Minister Sergey Lavrov, told reporters after the meeting in Hamburg that Trump had been persuaded by Putin's arguments.

10 July 2017
Sourav Ganguly says Virat Kohli needs to understand how coaches operate
Further elaborating the decision, Ganguly said that he, along with Sachin Tendulkar and V.V.S. So we understand where it goes. "We want the best possible thing".

10 July 2017
Tottenham target £10m move for Argentine defender
Estudiantes president Juan Veron, the former Manchester United and Chelsea midfielder, was due to fly for discussions in the coming days, possibly in Italy.

10 July 2017
Anurag Thakur told to offer fresh unconditional apology
When asked if the BCCI wanted this recommendation to be removed entirely, Choudhary only said, "it needs a review". The meeting was attended by chairman Rajiv Shukla, Naba Bhattacharjee, Jay Shah, Anirudh Chaudhry and Choudhary.

10 July 2017
Wild West Online Receives Official Pre-Alpha Gameplay Trailer
The producer then proceeds to show off the game's costume system and its in-game gambling choices found inside a town's saloon. However, he demonstrates in the video that stealing while no one else is looking does not affect a player's reputation .